awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48151417-E48BA354-9FD0-4D29-AFC3-09D0DE26C6EB
Q48151417-E48BA354-9FD0-4D29-AFC3-09D0DE26C6EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48151417-E48BA354-9FD0-4D29-AFC3-09D0DE26C6EB
Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.
P2860
Q48151417-E48BA354-9FD0-4D29-AFC3-09D0DE26C6EB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48151417-E48BA354-9FD0-4D29-AFC3-09D0DE26C6EB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
374caa9408b67e43f7c9b2062777ac2ce5bcdcaf
P2860
Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure.